Program Content

  • Treating MM
    Adapting to the Evolving Treatment Landscape for Multiple Myeloma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 07, 2021

    Expires: December 06, 2022

    View Activity
  • Therapeutic Landscape in MM
    Updates on the Rapidly Changing Therapeutic Landscape in Multiple Myeloma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 20, 2022

    Expires: April 19, 2023

    View Activity


cover img faculity

Brian G. M. Durie, MD

National Director, Hematologic Malignancies and Multiple Myeloma
Aptium Oncology, Inc.
Co-Chair, Myeloma Committee – SWOG
Chairman, International Myeloma Foundation
Specialist, Multiple Myeloma and Related Disorders
Cedars-Sinai Outpatient Cancer Center
Los Angeles, California

cover img faculity

Thomas G. Martin, MD

Associate Clinical Professor of Medicine
Associate Director
, Myeloma Institute
University of California, San Francisco Medical Center
San Francisco, California

cover img faculity

Vincent A. Miller, MD

Associate Attending Physician
Thoracic Oncology Service
Memorial Sloan-Kettering Cancer Center
New York, New York

cover img faculity

Philippe Moreau, MD

Professor of Clinical Hematology
Hematology Department
University Hospital Hôtel-Dieu
Nantes, France

cover img faculity

S. Vincent Rajkumar, MD

Professor of Medicine
Chair, Myeloma Amyloidosis Dysproteinemia Group
Mayo Clinic
Rochester, Minnesota

cover img faculity

Jesus San-Miguel, MD, PhD

Director of Clinical and Translational Medicine
Clinica Universidad de Navarra
Universidad de Navarra
Pamplona, Spain

cover img faculity

Jesús F. San-Miguel, MD, PhD

Head, Hematology Department
Professor of Medicine
Hospital Universitario de Salamanca and Centro de Investigación del Cáncer
University of Salamanca
Salamanca, Spain

Provided by

ProCE Banner


Bristol Myers Squibb

Genentech, a member of the Roche Group


Janssen administered by Scientific Affairs

Karyopharm Therapeutics


Pfizer, Inc.

Sanofi Genzyme


IMF 2021

ProCE Banner